Pedro Mondéjar-López

Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for <i>F508del</i> and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study

Marcus Mall, Rossa Brugha, Silvia Gärtner et al. · American Journal of Respiratory and Critical Care Medicine · 2022 · 140 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +15

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

Elliot McClenaghan, Rebecca Cosgriff, K. Brownlee et al. · Journal of Cystic Fibrosis · 2020 · 90 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +6

Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study

Robert Bain, Rebecca Cosgriff, Marco Zampoli et al. · Journal of Cystic Fibrosis · 2020 · 79 citations · Full text

Medicine, Infectious Diseases, Pediatrics +9

Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020

Lutz Naehrlich, Annalisa Orenti, Fiona Dunlevy et al. · Journal of Cystic Fibrosis · 2021 · 59 citations · Full text

Veterinary Medicine, Infectious Diseases, Disease Surveillance +8

Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

Pedro Mondéjar-López, Esther Quintana‐Gallego, Rosa Girón et al. · Respiratory Medicine · 2020 · 56 citations · Full text

Veterinary Medicine, Infectious Diseases, Disease Surveillance +10